Time In the Market on MSN
AbbVie’s Power Play: How Skyrizi, Rinvoq, and a Surging Brain Business Are Crushing It (Even if Botox Isn't)
AbbVie's Q3 2025 earnings are in. Skyrizi is on fire, neuroscience is booming, but Botox is a bust. Get the summary.
Branded patches from Rhode, Dior Beauty, and Starface point to logomania as the next big beauty frontier. But why are we so willing to wear brand logos on our face?
Junk bonds have a reputation of trading similar to stocks with respect to volatility. But Treasuries are considered to be the safe haven asset (for now). Thus, when HYG outperforms IEI, it's ...
The Chicago Bears are heading into an important matchup with the Cincinnati Bengals in Week 9 that could shape their strategy ahead of next week's trade deadline. A win over Cincinnati could give the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results